Pharmacokinetic/Pharmacodynamic Interactions Between Evogliptin and Glimepiride in Healthy Male Subjects

PURPOSE: Evogliptin, a dipeptidyl peptidase-4 inhibitor, and glimepiride, a sulfonylurea, are used to treat type 2 diabetes mellitus. In this study, we aimed to evaluate the pharmacokinetic (PK) and pharmacodynamic (PD) interactions between evogliptin and glimepiride. MATERIALS AND METHODS: A random...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoo, Hyounggyoon, Kim, Yun, Jang, In-Jin, Yu, Kyung-Sang, Lee, SeungHwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699451/
https://www.ncbi.nlm.nih.gov/pubmed/33262578
http://dx.doi.org/10.2147/DDDT.S275343

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699451/
https://www.ncbi.nlm.nih.gov/pubmed/33262578
http://dx.doi.org/10.2147/DDDT.S275343

Ejemplares similares